Zobrazeno 1 - 6
of 6
pro vyhledávání: '"pljučna fibroza"'
Autor:
Katja Perdan Pirkmajer, Alojzija Hočevar, Sonja Praprotnik, Matija Tomšič, Katarina Osolnik, Iztok Holc, Artur Pahor, Klara Svenšek, David Lestan, Žiga Rotar
Publikováno v:
Zdravniški Vestnik, Vol 92, Iss 5-6, Pp 267-274 (2023)
Vnetne revmatične bolezni so heterogena skupina bolezni, ki lahko prizadenejo tudi pljučni intersticij. Tako kot je pogostnost intersticijske pljučne bolezni (IPB) v okviru vnetnih revmatičnih bolezni variabilna, je tudi klinična slika zelo razn
Externí odkaz:
https://doaj.org/article/0b3f5aeb85dc42ad91ab8148cd6c9c4b
Publikováno v:
Cells, vol. 11, no. 3, pp. 1-9, 2022.
Cells, Vol 11, Iss 372, p 372 (2022)
Cells; Volume 11; Issue 3; Pages: 372
Cells, Vol 11, Iss 372, p 372 (2022)
Cells; Volume 11; Issue 3; Pages: 372
Recent studies have suggested that causative variants in telomerase complex genes (TCGs) are present in around 10% of individuals with idiopathic pulmonary fibrosis (IPF) regardless of family history of the disease. However, the studies used a case-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb2d582a897a89cf4c7deb14f8d5c321
https://pubmed.ncbi.nlm.nih.gov/35159182
https://pubmed.ncbi.nlm.nih.gov/35159182
Autor:
Katarina Tomovic, Mihajlo Gajić, Andrija Smelcerovic, Marko Anderluh, Dobrila Stankovic-Djordjevic, Vukica Djordjevic, Gordana Kocic
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in pharmacology, str. 1-4 : Ilustr., Vol. 11, 2020
COBISS-ID: 29551833
Frontiers in Pharmacology
Frontiers in pharmacology, vol. 11, 1185, 2020.
Frontiers in pharmacology, str. 1-4 : Ilustr., Vol. 11, 2020
COBISS-ID: 29551833
Frontiers in Pharmacology
Frontiers in pharmacology, vol. 11, 1185, 2020.
Since the outbreak of SARS-CoV-2 virus more than 12,500,000 cases have been reported worldwide. Patients suffering from diabetes and other comorbidities are particularly susceptible to severe forms of the COVID-19, which might result in chronic compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b577296c596e1284d86d993cd69f28c
https://pubmed.ncbi.nlm.nih.gov/32848788
https://pubmed.ncbi.nlm.nih.gov/32848788
Publikováno v:
Radiology and Oncology
Radiology and Oncology, Vol 53, Iss 3, Pp 357-361 (2019)
Radiology and oncology, vol. 53, no. 3, pp. 357-361, 2019.
Radiology and Oncology, Vol 53, Iss 3, Pp 357-361 (2019)
Radiology and oncology, vol. 53, no. 3, pp. 357-361, 2019.
Background The outcomes of patients with both lung cancer and idiopathic pulmonary fibrosis (IPF) are unfavorable. Therapeutic interventions for lung cancer such as surgery can cause acute exacerbation of IPF (aeIPF). This study aimed to assess the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e8d57d58a7f2bc526d84bbce077a37c
http://europepmc.org/articles/PMC6765158
http://europepmc.org/articles/PMC6765158
Autor:
Testen, Nika
Publikováno v:
Koper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3506::6e1578c3f7772f633b9d8119a8a4b150
https://plus.si.cobiss.net/opac7/bib/1541493700?lang=sl
https://plus.si.cobiss.net/opac7/bib/1541493700?lang=sl
Autor:
Janko, Tea
Publikováno v:
Koper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3506::c94bd330226e84ab535d15f04fac76e0
https://repozitorij.upr.si/IzpisGradiva.php?id=9852
https://repozitorij.upr.si/IzpisGradiva.php?id=9852